ArticleFrontiers in immunology2025

Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series.

Lantian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.